HUBUNGAN KOMORBID DENGAN KEPARAHAN COVID-19 DI RUMAH SAKIT DARURAT COVID-19 WISMA ATLET KEMAYORAN JAKARTA PUSAT TAHUN 2022
Keywords:
COVID-19, Comorbid, Severity
Abstract
challenge worldwide in the health sector related to the ongoing spread of the virus. More cases of death occur in the elderly and have co-morbidities. The purpose of this study was to analyze the relationship between comorbidities and COVID-19 severity at the Wisma Atlet Kemayoran Central Jakarta COVID-19 emergency hospital in 2022. The type of research was a survey with a cross-sectional study design. The study population was patients who were confirmed positive for COVID-19 with symptoms at the Wisma Atlet Kemayoran Emergency Hospital from July to December 2021. The study sample was 400 people. The results showed that the 6 variables studied, 4 variables that had a correlation with the severity of Covid-19 patients, namely hypertension from Sig. (2-tailed) 0.000, cardiovascular obtained Sig. (2-tailed) = 0.000, tuberculosis obtained Sig. (2-tailed) = 0.000 and comorbidities obtained Sig. (2-tailed) = 0.000. Meanwhile, diabetes mellitus and asthma do not have a correlation relationship with the severity level in Covid patients who obtained a Sig value. (2-tailed) respectively, namely = 0.483 and 0.599
References
Adab, P., Haroon, S., O’Hara, M. E., & Jordan, R. E. (2022). Comorbidities and covid-19. In bmj (Vol. 377). British Medical Journal Publishing Group.
Alkautsar, A. (2021). Hubungan Penyakit Komorbid dengan Tingkat Keparahan Pasien Covid-19. 03(01), 1488–1494.
Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(3), 247–250. https://doi.org/10.1016/j.dsx.2020.03.013
Baradaran, A., Ebrahimzadeh, M. H., Baradaran, A., & Kachooei, A. R. (2020). Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Archives of Bone and Joint Surgery, 8(Suppl 1), 247. https://doi.org/10.22038/abjs.2020.47754.2346
Ejaz, H. et al. (2020). ‗Journal of Infection and Public Health COVID-19 and comorbidities : Deleterious impact on infected patients‘, doi: Journal of Infection and Public Health, 13(12), Pp. 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014.
Galal, I., Hussein, A. A. R., Amin, M. T., Saad, M. M., Zayan, H. E. E., Abdelsayed, M. Z., Moustafa, M. M., Ezzat, A. R., Helmy, R. E. D., & Abd_Elaal, H. K. (2021). Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. The Egyptian Journal of Bronchology, 15(1), 1–8.
Gazzaz, Z. J. (2021). Diabetes and COVID-19. Open Life Sciences, 16(1), 297–302.
Giannini, S., Passeri, G., Tripepi, G., Sella, S., Fusaro, M., Arcidiacono, G., Torres, M. O., Michielin, A., Prandini, T., & Baffa, V. (2021). Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study. Nutrients, 13(1), 219.
Gonçalves, J., Juliano, A. M., Charepe, N., Alenquer, M., Athayde, D., Ferreira, F., Archer, M., Amorim, M. J., Serrano, F., & Soares, H. (2021). Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination. Cell Reports Medicine, 2(12), 100468.
Guan, W., Liang, W., He, J., & Zhong, N. (2020). Cardiovascular comorbidity and its impact on patients with COVID-19. European Respiratory Journal, 55(6).
Gülsen, A., König, I. R., Jappe, U., & Drömann, D. (2021). Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis. Respirology, 26(6), 552–565.
Kamyshnyi, A., Krynytska, I., Matskevych, V., Marushchak, M., & Lushchak, O. (2020). Arterial hypertension as a risk comorbidity associated with COVID-19 pathology. International Journal of Hypertension, 2020.
Kemenkes RI. (2021). Situasi Terkini Perkembangan Coronavirus Disease (Covid-19). https://infeksiemerging.kemkes.go.id/
Kompas.com. (2021). UPDATE 21 Oktober: 143.120 Orang di Indonesia Meninggal akibat Covid-19. 21 Oktober 2021. https://nasional.kompas.com/read/2021/10/21/18281271/update-21-oktober-143120-orang-di-indonesia-meninggal-akibat-covid-19
Lee, S. C., Son, K. J., Han, C. H., Jung, J. Y., & Park, S. C. (2020). Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Scientific Reports, 10(1), 1–9.
Liu, H., Chen, S., Liu, M., Nie, H., & Lu, H. (2020). Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging and Disease, 11(3), 668.
Liu, S., Cao, Y., Du, T., & Zhi, Y. (2021). Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. The Journal of Allergy and Clinical Immunology: In Practice, 9(2), 693–701.
Rangki, L., & Dalla, Fitriani, Alifariki, L. . (2020). Upaya pencegahan dan penanggulangan transmisi covid 19 melalui program KKN Tematik Mahasiswa Universitas Halu Oleo. Journal of Community Engagement in Health, 3(2), 266–274. https://doi.org/10.30994/jceh.v3i2.78
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020). Comorbidity and its impact on patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1069–1076.
Skevaki, C., Karsonova, A., Karaulov, A., Xie, M., & Renz, H. (2020). Asthma-associated risk for COVID-19 development. Journal of Allergy and Clinical Immunology, 146(6), 1295–1301.
Ssentongo, P., Ssentongo, A. E., Heilbrunn, E. S., Ba, D. M., & Chinchilli, V. M. (2020). Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PloS One, 15(8), e0238215.
Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 epidemic. Tropical Medicine & International Health, 25(3), 278.
WHO. (2021). Clinical management Clinical management Living guidance COVID-19‘. World Health Organization, (January).
WHO, U., & UNDP, F. A. O. (2022). COVID-19 UPDATE. WHO Switzerland.
Zhou, P., Yang, X. Lou, Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., Chen, H.D., Chen, J., Luo, Y., Guo, H., Jiang, R. Di, Liu, M.Q., Chen, Y., Shen, X.R., Wang, X., Zheng, X.S., Zhao, K., Chen, Q.J., Deng, F., Liu, L., Z. L. (2020). a pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature.
Alkautsar, A. (2021). Hubungan Penyakit Komorbid dengan Tingkat Keparahan Pasien Covid-19. 03(01), 1488–1494.
Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(3), 247–250. https://doi.org/10.1016/j.dsx.2020.03.013
Baradaran, A., Ebrahimzadeh, M. H., Baradaran, A., & Kachooei, A. R. (2020). Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Archives of Bone and Joint Surgery, 8(Suppl 1), 247. https://doi.org/10.22038/abjs.2020.47754.2346
Ejaz, H. et al. (2020). ‗Journal of Infection and Public Health COVID-19 and comorbidities : Deleterious impact on infected patients‘, doi: Journal of Infection and Public Health, 13(12), Pp. 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014.
Galal, I., Hussein, A. A. R., Amin, M. T., Saad, M. M., Zayan, H. E. E., Abdelsayed, M. Z., Moustafa, M. M., Ezzat, A. R., Helmy, R. E. D., & Abd_Elaal, H. K. (2021). Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. The Egyptian Journal of Bronchology, 15(1), 1–8.
Gazzaz, Z. J. (2021). Diabetes and COVID-19. Open Life Sciences, 16(1), 297–302.
Giannini, S., Passeri, G., Tripepi, G., Sella, S., Fusaro, M., Arcidiacono, G., Torres, M. O., Michielin, A., Prandini, T., & Baffa, V. (2021). Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study. Nutrients, 13(1), 219.
Gonçalves, J., Juliano, A. M., Charepe, N., Alenquer, M., Athayde, D., Ferreira, F., Archer, M., Amorim, M. J., Serrano, F., & Soares, H. (2021). Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination. Cell Reports Medicine, 2(12), 100468.
Guan, W., Liang, W., He, J., & Zhong, N. (2020). Cardiovascular comorbidity and its impact on patients with COVID-19. European Respiratory Journal, 55(6).
Gülsen, A., König, I. R., Jappe, U., & Drömann, D. (2021). Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis. Respirology, 26(6), 552–565.
Kamyshnyi, A., Krynytska, I., Matskevych, V., Marushchak, M., & Lushchak, O. (2020). Arterial hypertension as a risk comorbidity associated with COVID-19 pathology. International Journal of Hypertension, 2020.
Kemenkes RI. (2021). Situasi Terkini Perkembangan Coronavirus Disease (Covid-19). https://infeksiemerging.kemkes.go.id/
Kompas.com. (2021). UPDATE 21 Oktober: 143.120 Orang di Indonesia Meninggal akibat Covid-19. 21 Oktober 2021. https://nasional.kompas.com/read/2021/10/21/18281271/update-21-oktober-143120-orang-di-indonesia-meninggal-akibat-covid-19
Lee, S. C., Son, K. J., Han, C. H., Jung, J. Y., & Park, S. C. (2020). Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Scientific Reports, 10(1), 1–9.
Liu, H., Chen, S., Liu, M., Nie, H., & Lu, H. (2020). Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging and Disease, 11(3), 668.
Liu, S., Cao, Y., Du, T., & Zhi, Y. (2021). Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. The Journal of Allergy and Clinical Immunology: In Practice, 9(2), 693–701.
Rangki, L., & Dalla, Fitriani, Alifariki, L. . (2020). Upaya pencegahan dan penanggulangan transmisi covid 19 melalui program KKN Tematik Mahasiswa Universitas Halu Oleo. Journal of Community Engagement in Health, 3(2), 266–274. https://doi.org/10.30994/jceh.v3i2.78
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020). Comorbidity and its impact on patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1069–1076.
Skevaki, C., Karsonova, A., Karaulov, A., Xie, M., & Renz, H. (2020). Asthma-associated risk for COVID-19 development. Journal of Allergy and Clinical Immunology, 146(6), 1295–1301.
Ssentongo, P., Ssentongo, A. E., Heilbrunn, E. S., Ba, D. M., & Chinchilli, V. M. (2020). Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PloS One, 15(8), e0238215.
Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 epidemic. Tropical Medicine & International Health, 25(3), 278.
WHO. (2021). Clinical management Clinical management Living guidance COVID-19‘. World Health Organization, (January).
WHO, U., & UNDP, F. A. O. (2022). COVID-19 UPDATE. WHO Switzerland.
Zhou, P., Yang, X. Lou, Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., Chen, H.D., Chen, J., Luo, Y., Guo, H., Jiang, R. Di, Liu, M.Q., Chen, Y., Shen, X.R., Wang, X., Zheng, X.S., Zhao, K., Chen, Q.J., Deng, F., Liu, L., Z. L. (2020). a pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature.
